{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T23:08:42Z","timestamp":1721084922689},"reference-count":154,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>Borderline Personality Disorder (BPD) is a chronic debilitating psychiatric disorder\ncharacterized mainly by emotional instability, chaotic interpersonal relationships, cognitive disturbance\n(e.g., dissociation and suicidal thoughts) and maladaptive behaviors. BPD has a high rate of\ncomorbidity with other mental disorders and a high burden on society. In this review, we focused\non two compromised brain regions in BPD - the hypothalamus and the corticolimbic system, emphasizing\nthe involvement and potential contribution of the endocannabinoid system (ECS) to improvement\nin symptoms and coping. The hypothalamus-regulated endocrine axes (hypothalamic\npituitary \u2013 gonadal, thyroid &amp; adrenal) have been found to be dysregulated in BPD. There is also\nsubstantial evidence for limbic system structural and functional changes in BPD, especially in the\namygdala and hippocampus, including cortical regions within the corticolimbic system. Extensive\nexpression of CB1 and CB2 receptors of the ECS has been found in limbic regions and the hypothalamus.\nThis opens new windows of opportunity for treatment with cannabinoids such as cannabidiol\n(CBD) as no other pharmacological treatment has shown long-lasting improvement in the\nBPD population to date. This review aims to show the potential role of the ECS in BPD patients\nthrough their most affected brain regions, the hypothalamus and the corticolimbic system. The literature\nreviewed does not allow for general indications of treatment with CBD in BPD. However,\nthere is enough knowledge to indicate a treatment ratio of a high level of CBD to a low level of\nTHC. A randomized controlled trial investigating the efficacy of cannabinoid based treatments in\nBPD is warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666200429234430","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T12:40:51Z","timestamp":1588250451000},"page":"360-371","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives"],"prefix":"10.2174","volume":"19","author":[{"given":"Sari G.","family":"Ferber","sequence":"first","affiliation":[{"name":"Psychology Department, Bar-Ilan University, Ramat Gan,Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reut","family":"Hazani","sequence":"additional","affiliation":[{"name":"Psychology Department, Bar-Ilan University, Ramat Gan,Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Shoval","sequence":"additional","affiliation":[{"name":"Geha Mental Health Center, Petah Tiqva,Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Weller","sequence":"additional","affiliation":[{"name":"Psychology Department, Bar-Ilan University, Ramat Gan,Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1092852915000310","volume":"20","author":"Coccaro E.F.","year":"2015","unstructured":"Coccaro E.F.; Fanning J.R.; Phan K.L.; Lee R.; Serotonin and impulsive aggression. CNS Spectr 2015,20(3),295-302","journal-title":"CNS Spectr"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fnhum.2014.00848","volume":"8","author":"Krause-Utz A.","year":"2014","unstructured":"Krause-Utz A.; Elzinga B.M.; Oei N.Y.L.; Paret C.; Niedtfeld I.; Spinhoven P.; Bohus M.; Schmahl C.; Amygdala and dorsal anterior cingulate connectivity during an emotional working memory task in borderline personality disorder patients with interpersonal trauma history. Front Hum Neurosci 2014,8(October),848","journal-title":"Front Hum Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11920-017-0757-y","volume":"19","author":"Krause-Utz A.","year":"2017","unstructured":"Krause-Utz A.; Frost R.; Winter D.; Elzinga B.M.; Dissociation and alterations in brain function and structure: implications for borderline personality disorder. Curr Psychiatry Rep 2017,19(1),6","journal-title":"Curr Psychiatry Rep"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61422-5","volume":"377","author":"Leichsenring F.","unstructured":"Leichsenring F.; Leibing E.; Kruse J.; New A.; Lancet F.L-T.; U. Borderline personality disorder\u200f.\u200f, 2011 Lancet 2011 ,377","journal-title":"Lancet 2011"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000330893","volume":"45","author":"Marissen M.A.E.","year":"2012","unstructured":"Marissen M.A.E.; Arnold N.; Franken I.H.A.; Anhedonia in borderline personality disorder and its relation to symptoms of impulsivity. Psychopathology 2012,45(3),179-184","journal-title":"Psychopathology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0006-3223(02)01324-0","volume":"51","author":"Skodol A.E.","year":"2002","unstructured":"Skodol A.E.; Gunderson J.G.; Pfohl B.; Widiger T.A.; Livesley W.J.; Siever L.J.; The borderline diagnosis i: psychopathology, comorbidity, and personaltity structure. Biol Psychiatry 2002,51(12),936-950","journal-title":"Biol Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10673220902996734","volume":"17","author":"Zimmerman D.J.","year":"2009","unstructured":"Zimmerman D.J.; Choi-Kain L.W.; The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review. Harv Rev Psychiatry 2009,17(3),167-183","journal-title":"Harv Rev Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/pmh.1365","volume":"11","author":"Cirasola A.","year":"2017","unstructured":"Cirasola A.; Hillman S.; Fonagy P.; Chiesa M.; Mapping the road from childhood adversity to personality disorder: The role of unresolved states of mind. Pers Ment Health 2017,11(2),77-90","journal-title":"Pers Ment Health"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1521\/pedi_2015_29_186","volume":"30","author":"Infurna M.R.","year":"2016","unstructured":"Infurna M.R.; Brunner R.; Holz B.; Parzer P.; Giannone F.; Reichl C.; Fischer G.; Resch F.; Kaess M.; The specific role of childhood abuse, parental bonding, and family functioning in female adolescents with borderline personality disorder. J Pers Disord 2016,30(2),177-192","journal-title":"J Pers Disord"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpsychires.2014.06.011","volume":"57","author":"Mart\u00edn-Blanco A.","year":"2014","unstructured":"Mart\u00edn-Blanco A.; Ferrer M.; Soler J.; Salazar J.; Vega D.; Andi\u00f3n O.; Sanchez-Mora C.; Arranz M.J.; Ribases M.; Feliu-Soler A.; P\u00e9rez V.; Pascual J.C.; Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. J Psychiatr Res 2014,57,34-40","journal-title":"J Psychiatr Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1017\/S0033291714002128","volume":"45","author":"Winsper C.","year":"2015","unstructured":"Winsper C.; Wolke D.; Lereya T.; Prospective associations between prenatal adversities and borderline personality disorder at 11-12 years. Psychol Med 2015,45(5),1025-1037","journal-title":"Psychol Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fpsyt.2019.00156","volume":"10","author":"Duque-Alarc\u00f3n X.","year":"2019","unstructured":"Duque-Alarc\u00f3n X.; Alcal\u00e1-Lozano R.; Gonz\u00e1lez-Olvera J.J.; Garza-Villarreal E.A.; Pellicer F.; Effects of Childhood maltreatment on social cognition and brain functional connectivity in borderline personality disorder patients. Front Psychiatry 2019,10,156","journal-title":"Front Psychiatry"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chiabu.2019.104222","volume":"98","author":"Turniansky H.","year":"2019","unstructured":"Turniansky H.; Ben-Dor D.; Krivoy A.; Weizman A.; Shoval G.; A history of prolonged childhood sexual abuse is associated with more severe clinical presentation of borderline personality disorder in adolescent female inpatients - A naturalistic study. Child Abuse Negl 2019,98","journal-title":"Child Abuse Negl"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","volume":"58","author":"Torgersen S.","year":"2001","unstructured":"Torgersen S.; Kringlen E.; Cramer V.; The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001,58(6),590-596","journal-title":"Arch Gen Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12888-016-0939-x","volume":"16","author":"Ten Have M.","year":"2016","unstructured":"Ten Have M.; Verheul R.; Kaasenbrood A.; van Dorsselaer S.; Tuithof M.; Kleinjan M.; de Graaf R.; Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study-2. BMC Psychiatry 2016,16(1),249","journal-title":"BMC Psychiatry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4088\/JCP.v69n0404","volume":"69","author":"Grant B.F.","year":"2008","unstructured":"Grant B.F.; Chou S.P.; Goldstein R.B.; Huang B.; Stinson F.S.; Saha T.D.; Smith S.M.; Dawson D.A.; Pulay A.J.; Pickering R.P.; Ruan W.J.; Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2008,69(4),533-545","journal-title":"J Clin Psychiatry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0010-440X(03)00090-7","volume":"44","author":"Johnson D.M.","year":"2003","unstructured":"Johnson D.M.; Shea M.T.; Yen S.; Battle C.L.; Zlotnick C.; Sanislow C.A.; Grilo C.M.; Skodol A.E.; Bender D.S.; McGlashan T.H.; Gunderson J.G.; Zanarini M.C.; Gender differences in borderline personality disorder: findings from the collaborative longitudinal personality disorders study. Compr Psychiatry 2003,44(4),284-292","journal-title":"Compr Psychiatry"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005653.pub2","author":"Stoffers J.","year":"2010","unstructured":"Stoffers J.; V\u00f6llm B.A.; R\u00fccker G.; Timmer A.; Huband N.; Lieb K.; Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev 2010(6)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0006-3223(02)01395-1","volume":"52","author":"Rinne T.","year":"2002","unstructured":"Rinne T.; de Kloet E.R.; Wouters L.; Goekoop J.G.; DeRijk R.H.; van den Brink W.; Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone\/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002,52(11),1102-1112","journal-title":"Biol Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/JCP.0b013e3181b2b9f3","volume":"29","author":"Saunders E.F.H.","year":"2009","unstructured":"Saunders E.F.H.; Silk K.R.; Personality trait dimensions and the pharmacological treatment of borderline personality disorder. J Clin Psychopharmacol 2009,29(5),461-467","journal-title":"J Clin Psychopharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.euroneuro.2015.03.017","volume":"25","author":"Bridler R.","year":"2015","unstructured":"Bridler R.; H\u00e4berle A.; M\u00fcller S.T.; Cattapan K.; Grohmann R.; Toto S.; Kasper S.; Greil W.; Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. Eur Neuropsychopharmacol 2015,25(6),763-772","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fendo.2014.00139","volume":"5","author":"Casta\u00f1eda C.D.C.","year":"2014","unstructured":"Casta\u00f1eda C.D.C.; Langlois V.S.; Fernandino J.I.; Crossover of the hypothalamic pituitary-adrenal\/interrenal, -thyroid, and -gonadal axes in testicular development. Front Endocrinol (Lausanne) 2014,5,139","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ygcen.2013.02.038","volume":"192","author":"Flood D.E.K.","year":"2013","unstructured":"Flood D.E.K.; Fernandino J.I.; Langlois V.S.; Thyroid hormones in male reproductive development: evidence for direct crosstalk between the androgen and thyroid hormone axes. Gen Comp Endocrinol 2013,192,2-14","journal-title":"Gen Comp Endocrinol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/etc.3995","volume":"37","author":"Br\u00fcggemann M.","year":"2018","unstructured":"Br\u00fcggemann M.; Licht O.; Fetter \u00c9.; Teigeler M.; Sch\u00e4fers C.; Eilebrecht E.; Knotting nets: Molecular junctions of interconnecting endocrine axes identified by application of the adverse outcome pathway concept. Environ Toxicol Chem 2018,37(2),318-328","journal-title":"Environ Toxicol Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000026673","volume":"42","author":"Cotrufo P.","year":"2000","unstructured":"Cotrufo P.; Monteleone P.; d\u2019Istria M.; Fuschino A.; Serino I.; Maj M.; Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa. Neuropsychobiology 2000,42(2),58-61","journal-title":"Neuropsychobiology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.psyneuen.2015.02.002","volume":"55","author":"Rausch J.","year":"2015","unstructured":"Rausch J.; G\u00e4bel A.; Nagy K.; Kleindienst N.; Herpertz S.C.; Bertsch K.; Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter. Psychoneuroendocrinology 2015,55,116-127","journal-title":"Psychoneuroendocrinology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.psyneuen.2016.05.026","volume":"71","author":"Dettenborn L.","year":"2016","unstructured":"Dettenborn L.; Kirschbaum C.; Gao W.; Spitzer C.; Roepke S.; Otte C.; Wingenfeld K.; Increased hair testosterone but unaltered hair cortisol in female patients with borderline personality disorder. Psychoneuroendocrinology 2016,71,176-179","journal-title":"Psychoneuroendocrinology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biopsycho.2015.03.016","volume":"109","author":"Eisenlohr-Moul T.A.","year":"2015","unstructured":"Eisenlohr-Moul T.A.; DeWall C.N.; Girdler S.S.; Segerstrom S.C.; Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone. Biol Psychol 2015,109,37-52","journal-title":"Biol Psychol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0004867417730650","volume":"52","author":"Tan R.Y.","year":"2018","unstructured":"Tan R.Y.; Grigg J.; Kulkarni J.; Borderline personality disorder and polycystic ovary syndrome: A review of the literature. Aust N Z J Psychiatry 2018,52(2),117-128","journal-title":"Aust N Z J Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/01.psy.0000197644.95292.00","volume":"68","author":"Goldstein-Ferber S.","year":"2006","unstructured":"Goldstein-Ferber S.; Granot M.; The association between somatization and perceived ability: roles in dysmenorrhea among Israeli Arab adolescents. Psychosom Med 2006,68(1),136-142","journal-title":"Psychosom Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0006-3223(93)90077-Q","volume":"34","author":"Kavoussi R.J.","year":"1993","unstructured":"Kavoussi R.J.; Coccaro E.F.; Klar H.; Lesser J.; Siever L.J.; The TRH-stimulation test in DSM-III personality disorder. Biol Psychiatry 1993,34(4),234-239","journal-title":"Biol Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/0006-3223(95)00394-0","volume":"40","author":"De la Fuente J.M.","year":"1996","unstructured":"De la Fuente J.M.; Mendlewicz J.; TRH stimulation and dexamethasone suppression in borderline personality disorder. Biol Psychiatry 1996,40(5),412-418","journal-title":"Biol Psychiatry"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-3956(01)00056-5","volume":"36","author":"De la Fuente J.M.","year":"2002","unstructured":"De la Fuente J.M.; Bobes J.; Vizuete C.; Mendlewicz J.; Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. J Psychiatr Res 2002,36(3),137-145","journal-title":"J Psychiatr Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0278-5846(01)00297-4","volume":"26","author":"Kioukia-Fougia N.","year":"2002","unstructured":"Kioukia-Fougia N.; Antoniou K.; Bekris S.; Liapi C.; Christofidis I.; Papadopoulou-Daifoti Z.; The effects of stress exposure on the hypothalamic-pituitary-adrenal axis, thymus, thyroid hormones and glucose levels. Prog Neuropsychopharmacol Biol Psychiatry 2002,26(5),823-830","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12888-017-1383-2","volume":"17","author":"Cattane N.","year":"2017","unstructured":"Cattane N.; Rossi R.; Lanfredi M.; Cattaneo A.; Borderline personality disorder and childhood trauma: exploring the affected biological systems and mechanisms. BMC Psychiatry 2017,17(1),221","journal-title":"BMC Psychiatry"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v5.23911","volume":"5","author":"Sinai C.","year":"2014","unstructured":"Sinai C.; Hirvikoski T.; Nordstr\u00f6m A.L.; Nordstr\u00f6m P.; Nilsonne A.; Wilczek A.; \u00c5sberg M.; Jokinen J.; Hypothalamic pituitary thyroid axis and exposure to interpersonal violence in childhood among women with borderline personality disorder. Eur J Psychotraumatol 2014,5(Suppl.)","journal-title":"Eur J Psychotraumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.psychres.2015.03.025","volume":"227","author":"Sinai C.","year":"2015","unstructured":"Sinai C.; Hirvikoski T.; Nordstr\u00f6m A.L.; Nordstr\u00f6m P.; Nilsonne \u00c5.; Wilczek A.; \u00c5sberg M.; Jokinen J.; Thyroid hormones and adult interpersonal violence among women with borderline personality disorder. Psychiatry Res 2015,227(2-3),253-257","journal-title":"Psychiatry Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pnpbp.2017.07.015","volume":"85","author":"Raymond C.","year":"2018","unstructured":"Raymond C.; Marin M.F.; Majeur D.; Lupien S.; Early child adversity and psychopathology in adulthood: HPA axis and cognitive dysregulations as potential mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 2018,85,152-160","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrn2639","volume":"10","author":"Lupien S.J.","year":"2009","unstructured":"Lupien S.J.; McEwen B.S.; Gunnar M.R.; Heim C.; Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009,10(6),434-445","journal-title":"Nat Rev Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11920-009-0010-4","volume":"11","author":"Ball J.S.","year":"2009","unstructured":"Ball J.S.; Links P.S.; Borderline personality disorder and childhood trauma: evidence for a causal relationship. Curr Psychiatry Rep 2009,11(1),63-68","journal-title":"Curr Psychiatry Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neubiorev.2018.11.008","volume":"96","author":"Drews E.","year":"2019","unstructured":"Drews E.; Fertuck E.A.; Koenig J.; Kaess M.; Arntz A.; Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis. Neurosci Biobehav Rev 2019,96,316-334","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.psyneuen.2014.10.009","volume":"51","author":"Wingenfeld K.","year":"2015","unstructured":"Wingenfeld K.; Wolf O.T.; Effects of cortisol on cognition in major depressive disorder, posttraumatic stress disorder and borderline personality disorder - 2014 Curt Richter Award Winner. Psychoneuroendocrinology 2015,51,282-295","journal-title":"Psychoneuroendocrinology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1176\/ajp.148.12.1647","volume":"148","author":"Siever L.J.","year":"1991","unstructured":"Siever L.J.; Davis K.L.; A psychobiological perspective on the personality disorders. Am J Psychiatry 1991,148(12),1647-1658","journal-title":"Am J Psychiatry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0165-1781(03)00237-3","volume":"121","author":"Paris J.","year":"2004","unstructured":"Paris J.; Zweig-Frank H.; Kin N.M.; Schwartz G.; Steiger H.; Nair N.P.V.; Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res 2004,121(3),239-252","journal-title":"Psychiatry Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psyneuen.2016.06.010","volume":"72","author":"Aleknaviciute J.","year":"2016","unstructured":"Aleknaviciute J.; Tulen J.H.M.; Kamperman A.M.; de Rijke Y.B.; Kooiman C.G.; Kushner S.A.; Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress. Psychoneuroendocrinology 2016,72,131-138","journal-title":"Psychoneuroendocrinology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000456549","volume":"50","author":"Kaess M.","year":"2017","unstructured":"Kaess M.; Whittle S.; Simmons J.G.; Jovev M.; Allen N.B.; Chanen A.M.; The interaction of childhood maltreatment, sex, and borderline personality features in the prediction of the cortisol awakening response in adolescents. Psychopathology 2017,50(3),188-194","journal-title":"Psychopathology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.psyneuen.2010.06.002","volume":"35","author":"Nater U.M.","year":"2010","unstructured":"Nater U.M.; Bohus M.; Abbruzzese E.; Ditzen B.; Gaab J.; Kleindienst N.; Ebner-Priemer U.; Mauchnik J.; Ehlert U.; Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder. Psychoneuroendocrinology 2010,35(10),1565-1572","journal-title":"Psychoneuroendocrinology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.brainresbull.2012.10.003","volume":"93","author":"Haller J.","year":"2013","unstructured":"Haller J.; The neurobiology of abnormal manifestations of aggression--a review of hypothalamic mechanisms in cats, rodents, and humans. Brain Res Bull 2013,93,97-109","journal-title":"Brain Res Bull"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.nmd.0000198138.41709.4f","volume":"194","author":"Conklin C.Z.","year":"2006","unstructured":"Conklin C.Z.; Bradley R.; Westen D.; Affect regulation in borderline personality disorder. J Nerv Ment Dis 2006,194(2),69-77","journal-title":"J Nerv Ment Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1037\/0021-843X.115.4.850","volume":"115","author":"Gratz K.L.","year":"2006","unstructured":"Gratz K.L.; Rosenthal M.Z.; Tull M.T.; Lejuez C.W.; Gunderson J.G.; An experimental investigation of emotion dysregulation in borderline personality disorder. J Abnorm Psychol 2006,115(4),850-855","journal-title":"J Abnorm Psychol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psychres.2015.04.008","volume":"228","author":"Inoue A.","year":"2015","unstructured":"Inoue A.; Oshita H.; Maruyama Y.; Tanaka Y.; Ishitobi Y.; Kawano A.; Ikeda R.; Ando T.; Aizawa S.; Masuda K.; Higuma H.; Kanehisa M.; Ninomiya T.; Akiyoshi J.; Gender determines cortisol and alpha-amylase responses to acute physical and psychosocial stress in patients with borderline personality disorder. Psychiatry Res 2015,228(1),46-52","journal-title":"Psychiatry Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.psyneuen.2018.12.009","volume":"102","author":"Thomas N.","year":"2019","unstructured":"Thomas N.; Gurvich C.; Hudaib A.R.; Gavrilidis E.; Kulkarni J.; Systematic review and meta-analysis of basal cortisol levels in Borderline Personality Disorder compared to non-psychiatric controls. Psychoneuroendocrinology 2019,102,149-157","journal-title":"Psychoneuroendocrinology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psiq.2012.06.001","volume":"19","author":"Coccaro E.F.","year":"2012","unstructured":"Coccaro E.F.; Sripada C.S.; Yanowitch R.N.; Luan Phan K.; Corticolimbic function in impulsive aggressive behavior. Psiquiatr Biol 2012,19(2),46-53","journal-title":"Psiquiatr Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/scan\/nsw016","volume":"11","author":"Paret C.","year":"2016","unstructured":"Paret C.; Kluetsch R.; Zaehringer J.; Ruf M.; Demirakca T.; Bohus M.; Ende G.; Schmahl C.; Alterations of amygdala-prefrontal connectivity with real-time fMRI neurofeedback in BPD patients. Soc Cogn Affect Neurosci 2016,11(6),952-960","journal-title":"Soc Cogn Affect Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40473-018-0146-9","volume":"5","author":"Krause-Utz A.","year":"2018","unstructured":"Krause-Utz A.; Elzinga B.; Current understanding of the neural mechanisms of dissociation in borderline Personality Disorder. Curr Behav Neurosci Rep 2018,5(1),113-123","journal-title":"Curr Behav Neurosci Rep"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pscychresns.2007.07.001","volume":"163","author":"Buchheim A.","year":"2008","unstructured":"Buchheim A.; Erk S.; George C.; K\u00e4chele H.; Kircher T.; Martius P.; Pokorny D.; Ruchsow M.; Spitzer M.; Walter H.; Neural correlates of attachment trauma in borderline personality disorder: a functional magnetic resonance imaging study. Psychiatry Res 2008,163(3),223-235","journal-title":"Psychiatry Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fnhum.2016.00389","volume":"10","author":"Buchheim A.","year":"2016","unstructured":"Buchheim A.; Erk S.; George C.; K\u00e4chele H.; Martius P.; Pokorny D.; Spitzer M.; Walter H.; Neural Response during the activation of the attachment system in patients with borderline personality disorder: An fMRI study. Front Hum Neurosci 2016,10,389","journal-title":"Front Hum Neurosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jpsychires.2007.07.015","volume":"42","author":"Minzenberg M.J.","year":"2008","unstructured":"Minzenberg M.J.; Fan J.; New A.S.; Tang C.Y.; Siever L.J.; Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res 2008,42(9),727-733","journal-title":"J Psychiatr Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0006-3223(01)01075-7","volume":"50","author":"Herpertz S.C.","year":"2001","unstructured":"Herpertz S.C.; Dietrich T.M.; Wenning B.; Krings T.; Erberich S.G.; Willmes K.; Thron A.; Sass H.; Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry 2001,50(4),292-298","journal-title":"Biol Psychiatry"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1176\/appi.ajp.2013.13070852","volume":"171","author":"Koenigsberg H.W.","year":"2014","unstructured":"Koenigsberg H.W.; Denny B.T.; Fan J.; Liu X.; Guerreri S.; Mayson S.J.; Rimsky L.; New A.S.; Goodman M.; Siever L.J.; The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients. Am J Psychiatry 2014,171(1),82-90","journal-title":"Am J Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pscychresns.2008.07.010","volume":"172","author":"Koenigsberg H.W.","year":"2009","unstructured":"Koenigsberg H.W.; Siever L.J.; Lee H.; Pizzarello S.; New A.S.; Goodman M.; Cheng H.; Flory J.; Prohovnik I.; Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res 2009,172(3),192-199","journal-title":"Psychiatry Res"},{"key":"ref=62","doi-asserted-by":"publisher","author":"Buchheim A.","unstructured":"Buchheim A.; Roth G.; Schiepek G.; Pogarell O.; Karch S.;  Neurobiology of Borderline Personality Disorder (BPD) and Antisocial Personality Disorder (APD). Schweiz. Arch. Neurol. Psychiatr., 2013, 164(4), 115-122. https:\/\/psycnet.apa.org\/doi\/10.4414\/sanp.2013.00156","DOI":"10.4414\/sanp.2013.00156"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11920-014-0438-z","volume":"16","author":"Krause-Utz A.","year":"2014","unstructured":"Krause-Utz A.; Winter D.; Niedtfeld I.; Schmahl C.; The latest neuroimaging findings in borderline personality disorder. Curr Psychiatry Rep 2014,16(3),438","journal-title":"Curr Psychiatry Rep"},{"key":"ref=64","first-page":"379","volume":"81","author":"McLott J.","year":"2013","unstructured":"McLott J.; Jurecic J.; Hemphill L.; Dunn K.S.; Development of an amygdalocentric neurocircuitry-reactive aggression theoretical model of emergence delirium in posttraumatic stress disorder: an integrative literature review. AANA J 2013,81(5),379-384 https:\/\/search.proquest.com\/docview\/1503497698?accountid=14483","journal-title":"AANA J"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.psychres.2018.11.025","volume":"277","author":"Raine A.","year":"2019","unstructured":"Raine A.; The neuromoral theory of antisocial, violent, and psychopathic behavior. Psychiatry Res 2019,277,64-69","journal-title":"Psychiatry Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neubiorev.2016.10.008","volume":"91","author":"Walker S.E.","year":"2018","unstructured":"Walker S.E.; Papilloud A.; Huzard D.; Sandi C.; The link between aberrant hypothalamic-pituitary-adrenal axis activity during development and the emergence of aggression-Animal studies. Neurosci Biobehav Rev 2018,91,138-152","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1503\/jpn.170102","volume":"43","author":"Bertsch K.","year":"2018","unstructured":"Bertsch K.; Roelofs K.; Roch P.J.; Ma B.; Hensel S.; Herpertz S.C.; Volman I.; Neural correlates of emotional action control in anger-prone women with borderline personality disorder. J Psychiatry Neurosci 2018,43(3),161-170","journal-title":"J Psychiatry Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pscychresns.2016.04.005","volume":"251","author":"Kimmel C.L.","year":"2016","unstructured":"Kimmel C.L.; Alhassoon O.M.; Wollman S.C.; Stern M.J.; Perez-Figueroa A.; Hall M.G.; Rompogren J.; Radua J.; Age-related parieto-occipital and other gray matter changes in borderline personality disorder: A meta-analysis of cortical and subcortical structures. Psychiatry Res Neuroimaging 2016,251,15-25","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.eurpsy.2010.07.005","volume":"26","author":"Rodrigues E.","year":"2011","unstructured":"Rodrigues E.; Wenzel A.; Ribeiro M.P.; Quarantini L.C.; Miranda-Scippa A.; de Sena E.P.; de Oliveira I.R.; Hippocampal volume in borderline personality disorder with and without comorbid posttraumatic stress disorder: a meta-analysis. Eur Psychiatry 2011,26(7),452-456","journal-title":"Eur Psychiatry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0006-3223(03)00636-X","volume":"54","author":"Donegan N.H.","year":"2003","unstructured":"Donegan N.H.; Sanislow C.A.; Blumberg H.P.; Fulbright R.K.; Lacadie C.; Skudlarski P.; Gore J.C.; Olson I.R.; McGlashan T.H.; Wexler B.E.; Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 2003,54(11),1284-1293","journal-title":"Biol Psychiatry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1503\/jpn.120039","volume":"38","author":"Kuhlmann A.","year":"2013","unstructured":"Kuhlmann A.; Bertsch K.; Schmidinger I.; Thomann P.A.; Herpertz S.C.; Morphometric differences in central stress-regulating structures between women with and without borderline personality disorder. J Psychiatry Neurosci 2013,38(2),129-137","journal-title":"J Psychiatry Neurosci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11920-009-0089-7","volume":"12","author":"Mauchnik J.","year":"2010","unstructured":"Mauchnik J.; Schmahl C.; The latest neuroimaging findings in borderline personality disorder. Curr Psychiatry Rep 2010,12(1),46-55","journal-title":"Curr Psychiatry Rep"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fpsyt.2019.00063","volume":"10","author":"Chye Y.","year":"2019","unstructured":"Chye Y.; Christensen E.; Solowij N.; Y\u00fccel M.; The endocannabinoid system and cannabidiol\u2019s promise for the treatment of substance use disorder. Front Psychiatry 2019,10,63","journal-title":"Front Psychiatry"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","volume":"90","author":"Sv\u00edzensk\u00e1 I.","year":"2008","unstructured":"Sv\u00edzensk\u00e1 I.; Dubov\u00fd P.; Sulcov\u00e1 A.; Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review. Pharmacol Biochem Behav 2008,90(4),501-511","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"Piomelli D.","year":"2003","unstructured":"Piomelli D.; The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003,4(11),873-884","journal-title":"Nat Rev Neurosci"},{"key":"ref=76","author":"Wilson R. I.","unstructured":"Wilson R. I.; Nicoll R. A.;  Endocannabinoid signaling in the brainScience (80-), 2002, 296(5568), 678-682","journal-title":"Endocannabinoid signaling in the brainScience (80-), 2002, 296(5568), 678-682"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"Glass M.","year":"1997","unstructured":"Glass M.; Dragunow M.; Faull R.L.; Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997,77(2),299-318","journal-title":"Neuroscience"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.1992.tb25953.x","volume":"654","author":"Herkenham M.","year":"1992","unstructured":"Herkenham M.; Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci 1992,654,19-32","journal-title":"Ann N Y Acad Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11920-018-0880-4","volume":"20","author":"Colino L.","year":"2018","unstructured":"Colino L.; Herranz-Herrer J.; Gil-Benito E.; Ponte-Lopez T.; Del Sol-Calderon P.; Rodrigo-Yanguas M.; Gil-Ligero M.; S\u00e1nchez-L\u00f3pez A.J.; de Leon J.; Blasco-Fontecilla H.; Cannabinoid receptors, mental pain and suicidal behavior: a systematic review. Curr Psychiatry Rep 2018,20(3),19","journal-title":"Curr Psychiatry Rep"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.irn.2015.10.002","volume":"125","author":"Trautmann S.M.","year":"2015","unstructured":"Trautmann S.M.; Sharkey K.A.; The endocannabinoid system and its role in regulating the intrinsic neural circuitry of the gastrointestinal tract. Int Rev Neurobiol 2015,125,85-126","journal-title":"Int Rev Neurobiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","volume":"129","author":"Wright K.","year":"2005","unstructured":"Wright K.; Rooney N.; Feeney M.; Tate J.; Robertson D.; Welham M.; Ward S.; Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 2005,129(2),437-453","journal-title":"Gastroenterology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","volume":"153","author":"Wright K.L.","year":"2008","unstructured":"Wright K.L.; Duncan M.; Sharkey K.A.; Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 2008,153(2),263-270","journal-title":"Br J Pharmacol"},{"key":"ref=83","author":"Van Sickle M. D.","unstructured":"Van Sickle M. D.; Duncan M.; Kingsley P. J.; Mouihate A.; Urbani P.; Mackie K.; Stella N.; Makriyannis A.; Piomelli D.; Davison J. S.; Marnett L. J.; Di Marzo V.; Pittman Q. J.; Patel K. D.; Sharkey K. A.;  Identification and functional characterization of brainstem cannabinoid CB2 receptorsScience (80-), 2005,310(5746), 329\u2013332","journal-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptorsScience (80-), 2005,310(5746), 329\u2013332"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"Gong J.P.","year":"2006","unstructured":"Gong J.P.; Onaivi E.S.; Ishiguro H.; Liu Q.R.; Tagliaferro P.A.; Brusco A.; Uhl G.R.; Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006,1071(1),10-23","journal-title":"Brain Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40263-019-00669-5","volume":"33","author":"Dos Santos R.G.","year":"2019","unstructured":"Dos Santos R.G.; de Lima Os\u00f3rio F.; Martin-Santos R.; Zuardi A.W.; Hallak J.E.C.; Crippa J.A.S.; Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs 2019,33(10),1031-1038","journal-title":"CNS Drugs"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/FBP.0000000000000068","volume":"25","author":"Marco E.M.","year":"2014","unstructured":"Marco E.M.; Echeverry-Alzate V.; L\u00f3pez-Moreno J.A.; Gin\u00e9 E.; Pe\u00f1asco S.; Viveros M.P.; Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain. Behav Pharmacol 2014,25(5-6),547-556","journal-title":"Behav Pharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1196\/annals.1432.037","volume":"1139","author":"Brusco A.","year":"2008","unstructured":"Brusco A.; Tagliaferro P.A.; Saez T.; Onaivi E.S.; Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 2008,1139,450-457","journal-title":"Ann N Y Acad Sci"},{"key":"ref=88","author":"Devane W. A.","unstructured":"Devane W. A.; Hanu\u0161 L.; Breuer A.; Pertwee R. G.; Stevenson L. A.; Griffin G.; Gibson D.; Mandelbaum A.; Etinger A.; Mechoulam R.;  Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science (80-), 1992, 258(5090),\t1946\u20131949","journal-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science (80-), 1992, 258(5090),\t1946\u20131949"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/hipo.22558","volume":"26","author":"Li Y.","year":"2016","unstructured":"Li Y.; Kim J.; Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus. Hippocampus 2016,26(3),275-281","journal-title":"Hippocampus"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"Mechoulam R.","year":"1995","unstructured":"Mechoulam R.; Ben-Shabat S.; Hanus L.; Ligumsky M.; Kaminski N.E.; Schatz A.R.; Gopher A.; Almog S.; Martin B.R.; Compton D.R.; Pertwee R.G.; Griffin G.; Bayewitch M.; Barg J.; Vogel Z.; Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995,50(1),83-90","journal-title":"Biochem Pharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fnmol.2017.00411","volume":"10","author":"Scarante F.F.","year":"2017","unstructured":"Scarante F.F.; Vila-Verde C.; Detoni V.L.; Ferreira-Junior N.C.; Guimar\u00e3es F.S.; Campos A.C.; Cannabinoid modulation of the stressed hippocampus. Front Mol Neurosci 2017,10,411","journal-title":"Front Mol Neurosci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","volume":"90","author":"Stempel A.V.","year":"2016","unstructured":"Stempel A.V.; Stumpf A.; Zhang H.Y.; \u00d6zdo\u011fan T.; Pannasch U.; Theis A.K.; Otte D.M.; Wojtalla A.; R\u00e1cz I.; Ponomarenko A.; Xi Z.X.; Zimmer A.; Schmitz D.; Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 2016,90(4),795-809","journal-title":"Neuron"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.neubiorev.2014.03.026","volume":"46","author":"Aguiar D.C.","year":"2014","unstructured":"Aguiar D.C.; Moreira F.A.; Terzian A.L.; Foga\u00e7a M.V.; Lisboa S.F.; Wotjak C.T.; Guimaraes F.S.; Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels. Neurosci Biobehav Rev 2014,46(Pt 3),418-428","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","volume":"834","author":"Micale V.","year":"2018","unstructured":"Micale V.; Drago F.; Endocannabinoid system, stress and HPA axis. Eur J Pharmacol 2018,834,230-239","journal-title":"Eur J Pharmacol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"Crippa J.A.S.","year":"2011","unstructured":"Crippa J.A.S.; Derenusson G.N.; Ferrari T.B.; Wichert-Ana L.; Duran F.L.S.; Martin-Santos R.; Sim\u00f5es M.V.; Bhattacharyya S.; Fusar-Poli P.; Atakan Z.; Santos Filho A.; Freitas-Ferrari M.C.; McGuire P.K.; Zuardi A.W.; Busatto G.F.; Hallak J.E.C.; Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (Oxford) 2011,25(1),121-130","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2018.05.027","volume":"351","author":"Hen-Shoval D.","year":"2018","unstructured":"Hen-Shoval D.; Amar S.; Shbiro L.; Smoum R.; Haj C.G.; Mechoulam R.; Zalsman G.; Weller A.; Shoval G.; Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression. Behav Brain Res 2018,351,1-3","journal-title":"Behav Brain Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1038\/sj.npp.1301092","volume":"31","author":"Hill M.N.","year":"2006","unstructured":"Hill M.N.; Ho W.S.V.; Sinopoli K.J.; Viau V.; Hillard C.J.; Gorzalka B.B.; Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 2006,31(12),2591-2599","journal-title":"Neuropsychopharmacology"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.physbeh.2018.12.019","volume":"201","author":"Shbiro L.","year":"2019","unstructured":"Shbiro L.; Hen-Shoval D.; Hazut N.; Rapps K.; Dar S.; Zalsman G.; Mechoulam R.; Weller A.; Shoval G.; Effects of cannabidiol in males and females in two different rat models of depression. Physiol Behav 2019,201,59-63","journal-title":"Physiol Behav"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000443890","volume":"73","author":"Shoval G.","year":"2016","unstructured":"Shoval G.; Shbiro L.; Hershkovitz L.; Hazut N.; Zalsman G.; Mechoulam R.; Weller A.; Prohedonic effect of cannabidiol in a rat model of depression. Neuropsychobiology 2016,73(2),123-129","journal-title":"Neuropsychobiology"},{"key":"ref=100","author":"Micale V.","unstructured":"Micale V.; Tabiova K.; Kucerova J.; Drago F.;  In: Cannabinoid Modulation of Emotion, Memory, and Motivation; Springer New York, 2015, pp 97-129","journal-title":"In: Cannabinoid Modulation of Emotion, Memory, and Motivation; Springer New York, 2015, pp 97-129"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","volume":"18","author":"Ferber S.G.","year":"2020","unstructured":"Ferber S.G.; Namdar D.; Hen-Shoval D.; Eger G.; Koltai H.; Shoval G.; Shbiro L.; Weller A.; The \u201cEntourage Effect\u201d: Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Curr Neuropharmacol 2020,18(2),87-96","journal-title":"Curr Neuropharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jad.2016.02.007","volume":"195","author":"Borges G.","year":"2016","unstructured":"Borges G.; Bagge C.L.; Orozco R.; A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord 2016,195,63-74","journal-title":"J Affect Disord"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jad.2016.07.010","volume":"205","author":"Shalit N.","year":"2016","unstructured":"Shalit N.; Shoval G.; Shlosberg D.; Feingold D.; Lev-Ran S.; The association between cannabis use and suicidality among men and women: A population-based longitudinal study. J Affect Disord 2016,205,216-224","journal-title":"J Affect Disord"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2006.05.002","volume":"48","author":"Shoval G.","year":"2007","unstructured":"Shoval G.; Zalsman G.; Apter A.; Diller R.; Sher L.; Weizman A.; A 10-year retrospective study of inpatient adolescents with schizophrenia\/schizoaffective disorder and substance use. Compr Psychiatry 2007,48(1),1-7","journal-title":"Compr Psychiatry"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/jpet.108.141069","volume":"328","author":"Trezza V.","year":"2009","unstructured":"Trezza V.; Vanderschuren L.J.M.J.; Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. J Pharmacol Exp Ther 2009,328(1),343-350","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neubiorev.2016.07.025","volume":"70","author":"Vanderschuren L.J.M.J.","year":"2016","unstructured":"Vanderschuren L.J.M.J.; Achterberg E.J.M.; Trezza V.; The neurobiology of social play and its rewarding value in rats. Neurosci Biobehav Rev 2016,70,86-105","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fnbeh.2016.00211","volume":"10","author":"Manduca A.","year":"2016","unstructured":"Manduca A.; Lassalle O.; Sepers M.; Campolongo P.; Cuomo V.; Marsicano G.; Kieffer B.; Vanderschuren L.J.M.J.; Trezza V.; Manzoni O.J.J.; Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play. Front Behav Neurosci 2016,10(NOV),211","journal-title":"Front Behav Neurosci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/10253890.2018.1451837","volume":"21","author":"Wingenfeld K.","year":"2018","unstructured":"Wingenfeld K.; Dettenborn L.; Kirschbaum C.; Gao W.; Otte C.; Roepke S.; Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. Stress 2018,21(4),366-369","journal-title":"Stress"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00406-013-0470-8","volume":"264","author":"Schaefer C.","year":"2014","unstructured":"Schaefer C.; Enning F.; Mueller J.K.; Bumb J.M.; Rohleder C.; Odorfer T.M.; Klosterk\u00f6tter J.; Hellmich M.; Koethe D.; Schmahl C.; Bohus M.; Leweke F.M.; Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. Eur Arch Psychiatry Clin Neurosci 2014,264(5),459-463","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"Hillard C.J.","year":"2018","unstructured":"Hillard C.J.; Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology 2018,43(1),155-172","journal-title":"Neuropsychopharmacology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnbeh.2018.00041","volume":"12","author":"Kolla N.J.","year":"2018","unstructured":"Kolla N.J.; Mishra A.; The endocannabinoid system, aggression, and the violence of synthetic cannabinoid use, borderline personality disorder, antisocial personality disorder, and other psychiatric disorders. Front Behav Neurosci 2018,12,41","journal-title":"Front Behav Neurosci"},{"key":"ref=112","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.04.003","author":"Dos Anjos-Garcia T.","unstructured":"Dos Anjos-Garcia T.; Ullah F.; Falconi-Sobrinho L.L.; Coimbra N.C.;  CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamusNeuropharmacology, 2017, 113(Pt A), 156-166","journal-title":"CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamusNeuropharmacology, 2017, 113(Pt A), 156-166"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.06.007","volume":"42","author":"Crowe M.S.","year":"2014","unstructured":"Crowe M.S.; Nass S.R.; Gabella K.M.; Kinsey S.G.; The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav Immun 2014,42,1-5","journal-title":"Brain Behav Immun"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137034","volume":"10","author":"Marco E.M.","year":"2015","unstructured":"Marco E.M.; Rapino C.; Caprioli A.; Borsini F.; Laviola G.; Maccarrone M.; Lodola A.; Potential therapeutic value of a novel faah inhibitor for the treatment of anxiety. PLoS One 2015,10(9)","journal-title":"PLoS One"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"Pagotto U.","year":"2006","unstructured":"Pagotto U.; Marsicano G.; Cota D.; Lutz B.; Pasquali R.; The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006,27(1),73-100","journal-title":"Endocr Rev"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","volume":"23","author":"Di S.","year":"2003","unstructured":"Di S.; Malcher-Lopes R.; Halmos K.C.; Tasker J.G.; Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003,23(12),4850-4857","journal-title":"J Neurosci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"Marsicano G.","year":"1999","unstructured":"Marsicano G.; Lutz B.; Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999,11(12),4213-4225","journal-title":"Eur J Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/ejn.12561","volume":"40","author":"Terzian A.L.B.","year":"2014","unstructured":"Terzian A.L.B.; Micale V.; Wotjak C.T.; Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. Eur J Neurosci 2014,40(1),2293-2298","journal-title":"Eur J Neurosci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnbeh.2011.00049","volume":"5","author":"Terzian A.L.","year":"2011","unstructured":"Terzian A.L.; Drago F.; Wotjak C.T.; Micale V.; The dopamine and cannabinoid interaction in the modulation of emotions and cognition: assessing the role of cannabinoid cb1 receptor in neurons expressing dopamine D1 receptors. Front Behav Neurosci 2011,5,49","journal-title":"Front Behav Neurosci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jpsychires.2017.02.002","volume":"90","author":"Micale V.","year":"2017","unstructured":"Micale V.; Stepan J.; Jurik A.; Pamplona F.A.; Marsch R.; Drago F.; Eder M.; Wotjak C.T.; Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. J Psychiatr Res 2017,90,46-59","journal-title":"J Psychiatr Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13048-018-0478-9","volume":"12","author":"Walker O.S.","year":"2019","unstructured":"Walker O.S.; Holloway A.C.; Raha S.; The role of the endocannabinoid system in female reproductive tissues. J Ovarian Res 2019,12(1),3","journal-title":"J Ovarian Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1210\/en.2004-1672","volume":"146","author":"Gammon C.M.","year":"2005","unstructured":"Gammon C.M.; Freeman G.M.; Xie W.; Petersen S.L.; Wetsel W.C.; Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 2005,146(10),4491-4499","journal-title":"Endocrinology"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"11891","DOI":"10.1073\/pnas.0404366101","volume":"101","author":"Scorticati C.","year":"2004","unstructured":"Scorticati C.; Fern\u00e1ndez-Solari J.; De Laurentiis A.; Mohn C.; Prestifilippo J.P.; Lasaga M.; Seilicovich A.; Billi S.; Franchi A.; McCann S.M.; Rettori V.; The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc Natl Acad Sci USA 2004,101(32),11891-11896","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1210\/endo-102-6-1808","volume":"102","author":"Tyrey L.","year":"1978","unstructured":"Tyrey L.; delta-9-Tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology 1978,102(6),1808-1814","journal-title":"Endocrinology"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1210\/jcem-52-1-50","volume":"52","author":"Asch R.H.","year":"1981","unstructured":"Asch R.H.; Smith C.G.; Siler-Khodr T.M.; Pauerstein C.J.; Effects of delta 9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta). J Clin Endocrinol Metab 1981,52(1),50-55","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=126","author":"Smith C. G.","unstructured":"Smith C. G.; Almirez R. G.; Berenberg J.; Asch R. H.;  Tolerance\tdevelops to the disruptive effects of \u03b49- tetrahydrocannabinol on primate menstrual cycle Science (80-), 1983, 219(4591), 1435-5","journal-title":"Tolerance\tdevelops to the disruptive effects of \u03b49- tetrahydrocannabinol on primate menstrual cycle Science (80-), 1983, 219(4591), 1435-5"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"Bergamaschi M.M.","year":"2011","unstructured":"Bergamaschi M.M.; Queiroz R.H.; Zuardi A.W.; Crippa J.A.; Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 2011,6(4),237-249","journal-title":"Curr Drug Saf"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0091-3057(84)90303-4","volume":"20","author":"Hillard C.J.","year":"1984","unstructured":"Hillard C.J.; Farber N.E.; Hagen T.C.; Bloom A.S.; The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacol Biochem Behav 1984,20(4),547-550","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/BF01968699","volume":"1","author":"Lomax P.","year":"1970","unstructured":"Lomax P.; The effect of marihuana on pituitary-thyroid activity in the rat. Agents Actions 1970,1(5),252-257","journal-title":"Agents Actions"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1677\/JOE-08-0380","volume":"199","author":"Liberato Costa Da Veiga M.A.","year":"2008","unstructured":"Liberato Costa Da Veiga M.A.; Fonseca Bloise F.; Henrique Costa-E-Sousa, R. Lopes Souza, L.; Aparecida, N.; Almeida, S.; Oliveira, K. J.; Cabanelas, Pazos-Moura, C. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. J Endocrinol 2008,199,235-242","journal-title":"J Endocrinol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"90S","DOI":"10.1002\/j.1552-4604.2002.tb06008.x","volume":"42","author":"Brown T.T.","year":"2002","unstructured":"Brown T.T.; Dobs A.S.; Endocrine effects of marijuana. J Clin Pharmacol 2002,42(S1),90S-96S","journal-title":"J Clin Pharmacol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/eje.0.1470255","volume":"147","author":"Porcella A.","year":"2002","unstructured":"Porcella A.; Marchese G.; Casu M.A.; Rocchitta A.; Lai M.L.; Gessa G.L.; Pani L.; Sc N.; Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. Eur J Endocrinol 2002,147(2),255-261","journal-title":"Eur J Endocrinol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yhbeh.2015.08.008","volume":"77","author":"Brummelte S.","year":"2016","unstructured":"Brummelte S.; Galea L.A.; Postpartum depression: Etiology, treatment and consequences for maternal care. Horm Behav 2016,77,153-166","journal-title":"Horm Behav"},{"key":"ref=134","volume":"101","author":"Ferrer A.","year":"2020","unstructured":"Ferrer A.; Labad J.; Salvat-Pujol N.; Monreal J.A.; Urretavizcaya M.; Crespo J.M.; Hypothalamic-pituitary-adrenal axis-related genes and cognition in major mood disorders and schizophrenia: a systematic review. Prog. Neuro-Psychopharmacol. Biol Psych 2020,101","journal-title":"Biol Psych"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/da.22692","volume":"35","author":"Fischer S.","year":"2018","unstructured":"Fischer S.; Ehlert U.; Hypothalamic\u2013Pituitary\u2013Thyroid (HPT) axis functioning in anxiety disorders. a systematic review. Dep Anxiety 2018,35(1),98-110","journal-title":"Dep Anxiety"},{"key":"ref=136","author":"Fischer S.","year":"2019","unstructured":"Fischer S.; Ehlert U.; Castro R.A.; Hormones of the hypothalamic-pituitary-gonadal (hpg) axis in male depressive disorders\u2013a systematic review and meta-analysis. Front Neuroendocrinol 2019","journal-title":"Front Neuroendocrinol"},{"key":"ref=137","first-page":"206","volume":"39","author":"Min W.","year":"2012","unstructured":"Min W.; Liu C.; Yang Y.; Sun X.; Zhang B.; Xu L.; Sun X.; Alterations in hypothalamic\u2013pituitary\u2013adrenal\/thyroid (hpa\/hpt) axes correlated with the clinical manifestations of depression. Prog. Neuro-Psychopharmacol. Biol Psych 2012,39(1),206-211","journal-title":"Biol Psych"},{"key":"ref=138","first-page":"14","volume":"4","author":"Seidman S.N.","year":"2003","unstructured":"Seidman S.N.; Estosterone deficiency and mood in aging Men: Pathogenic and therapeutic interactions. W J Biol Psych 2003,4(1),14-20","journal-title":"W J Biol Psych"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jad.2019.05.062","volume":"256","author":"Xie X.","year":"2019","unstructured":"Xie X.; Liu P.; Chen T.; Wang Y.; Liu X.; Influence of the hypothalamus\u2013pituitary\u2013gonadal axis reactivation and corresponding surging sex hormones on the amplitude of low-frequency oscillations in early pubertal girls: a resting state FMRI study. J Affect Disord 2019,256,288-294","journal-title":"J Affect Disord"},{"key":"ref=140","doi-asserted-by":"publisher","author":"Silveira M.M.","unstructured":"Silveira M.M.; Arnold J.C.; Laviolette S.R.; Hillard C.J.; Celorrio M.; Aymerich M.S.; Adams W.K.;  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. Neurosci. Biobehav. Rev., 2017, 76(Pt B), 380-395.","DOI":"10.1016\/j.neubiorev.2016.09.007"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","volume":"135","author":"Bahi A.","year":"2014","unstructured":"Bahi A.; Al Mansouri S.; Al Memari E.; Al Ameri M.; Nurulain S.M.; Ojha S.; \u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav 2014,135,119-124","journal-title":"Physiol Behav"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/gbb.12253","volume":"15","author":"Lee T.T.Y.","year":"2016","unstructured":"Lee T.T.Y.; Hill M.N.; Lee F.S.; Developmental regulation of fear learning and anxiety behavior by endocannabinoids. Genes Brain Behav 2016,15(1),108-124","journal-title":"Genes Brain Behav"},{"key":"ref=143","doi-asserted-by":"publisher","DOI":"10.1002\/dev.21944","author":"Goldstein F.S.","unstructured":"Goldstein F.S.; Trezza V.; Weller A.; Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping. Dev Psychobiol2019 Epub A Head of Print","journal-title":"Dev Psychobiol2019 Epub A Head of Print"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/10253890.2015.1117448","volume":"19","author":"McLaughlin R.J.","year":"2016","unstructured":"McLaughlin R.J.; Verlezza S.; Gray J.M.; Hill M.N.; Walker C.D.; Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions. Stress 2016,19(1),114-124","journal-title":"Stress"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2012.11.017","volume":"249","author":"Lee T.T.Y.","year":"2013","unstructured":"Lee T.T.Y.; Hill M.N.; Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB receptor binding in male rats. Neuroscience 2013,249,106-114","journal-title":"Neuroscience"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"13096","DOI":"10.1523\/JNEUROSCI.1297-14.2014","volume":"34","author":"Draycott B.","year":"2014","unstructured":"Draycott B.; Loureiro M.; Ahmad T.; Tan H.; Zunder J.; Laviolette S.R.; Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area. J Neurosci 2014,34(39),13096-13109","journal-title":"J Neurosci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1523\/JNEUROSCI.4718-10.2011","volume":"31","author":"Tan H.","year":"2011","unstructured":"Tan H.; Lauzon N.M.; Bishop S.F.; Chi N.; Bechard M.; Laviolette S.R.; Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci 2011,31(14),5300-5312","journal-title":"J Neurosci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","volume":"18","author":"Rubino T.","year":"2008","unstructured":"Rubino T.; Realini N.; Castiglioni C.; Guidali, C.; Vigano\u00b41, D.; Marras, E.; Petrosino, S.; Perletti, G.; Maccarrone, M.; Marzo, V. Di; Parolaro, D. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 2008,18,1292-1301","journal-title":"Cereb Cortex"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pnpbp.2015.01.005","volume":"59","author":"Lisboa S.F.","year":"2015","unstructured":"Lisboa S.F.; Borges A.A.; Nejo P.; Fassini A.; Guimar\u00e3es F.S.; Resstel L.B.; Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence. Prog Neuropsychopharmacol Biol Psychiatry 2015,59,76-83","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2012.123","volume":"37","author":"Rey A.A.","year":"2012","unstructured":"Rey A.A.; Purrio M.; Viveros M.P.; Lutz B.; Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 2012,37(12),2624-2634","journal-title":"Neuropsychopharmacology"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00213-019-05289-x","volume":"236","author":"Corniquel M.B.","year":"2019","unstructured":"Corniquel M.B.; Koenigsberg H.W.; Likhtik E.; Toward an animal model of borderline personality disorder. Psychopharmacology (Berl) 2019,236(8),2485-2500","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1574889809666140307115532","volume":"9","author":"Kucerova J.","year":"2014","unstructured":"Kucerova J.; Tabiova K.; Drago F.; Micale V.; Therapeutic potential of cannabinoids in schizophrenia. Recent Patents CNS Drug Discov 2014,9(1),13-25","journal-title":"Recent Patents CNS Drug Discov"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","volume":"146","author":"Stark T.","year":"2019","unstructured":"Stark T.; Ruda-Kucerova J.; Iannotti F.A.; D\u2019Addario C.; Di Marco R.; Pekarik V.; Drazanova E.; Piscitelli F.; Bari M.; Babinska Z.; Giurdanella G.; Di Bartolomeo M.; Salomone S.; Sulcova A.; Maccarrone M.; Wotjak C.T.; Starcuk Z.; Drago F.; Mechoulam R.; Di Marzo V.; Micale V.; Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. Neuropharmacology 2019,146,212-221","journal-title":"Neuropharmacology"},{"key":"ref=154","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.184","author":"Bhattacharyya S.","unstructured":"Bhattacharyya S.; Morrison P.D.; Fusar-Poli P.; Martin-Santos R.; Borgwardt S.; Winton-Brown T.; Nosarti C.; O\u2019 Carroll C.M.; Seal M.; Allen P.; Mehta M.A.; Stone J.M.; Tunstall N.; Giampietro V.; Kapur S.; Murray R.M.; Zuardi A.W.; Crippa J.A.; Atakan Z.; McGuire P.K.;  Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologyNeuropsychopharmacology, 2010, 35(3), 764-774","journal-title":"Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologyNeuropsychopharmacology, 2010, 35(3), 764-774"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666200429234430","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181504\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666200429234430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:33:54Z","timestamp":1655382834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181504\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":154,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200429234430","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}